vs
MIMEDX GROUP, INC.（MDXG）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
MIMEDX GROUP, INC.的季度营收约是RMR GROUP INC.的1.8倍（$118.1M vs $66.7M），RMR GROUP INC.净利率更高（18.3% vs 12.9%，领先5.4%），RMR GROUP INC.同比增速更快（40.8% vs 27.1%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
MDXG vs RMR — 直观对比
营收规模更大
MDXG
是对方的1.8倍
$66.7M
营收增速更快
RMR
高出13.7%
27.1%
净利率更高
RMR
高出5.4%
12.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $66.7M |
| 净利润 | $15.2M | $12.2M |
| 毛利率 | 83.9% | — |
| 营业利润率 | 17.8% | 48.1% |
| 净利率 | 12.9% | 18.3% |
| 营收同比 | 27.1% | 40.8% |
| 净利润同比 | 104.2% | 91.1% |
| 每股收益（稀释后） | $0.10 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRMR
| Q4 25 | $118.1M | $66.7M | ||
| Q3 25 | $113.7M | — | ||
| Q2 25 | $98.6M | — | ||
| Q1 25 | $88.2M | — | ||
| Q4 24 | $92.9M | — | ||
| Q3 24 | $84.1M | — | ||
| Q2 24 | $87.2M | — | ||
| Q1 24 | $84.7M | — |
净利润MDXGRMR
| Q4 25 | $15.2M | $12.2M | ||
| Q3 25 | $16.7M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $17.6M | — | ||
| Q1 24 | $9.3M | — |
毛利率MDXGRMR
| Q4 25 | 83.9% | — | ||
| Q3 25 | 83.5% | — | ||
| Q2 25 | 81.1% | — | ||
| Q1 25 | 81.2% | — | ||
| Q4 24 | 81.8% | — | ||
| Q3 24 | 81.8% | — | ||
| Q2 24 | 83.0% | — | ||
| Q1 24 | 84.7% | — |
营业利润率MDXGRMR
| Q4 25 | 17.8% | 48.1% | ||
| Q3 25 | 19.5% | — | ||
| Q2 25 | 12.5% | — | ||
| Q1 25 | 9.4% | — | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 26.9% | — | ||
| Q1 24 | 15.6% | — |
净利率MDXGRMR
| Q4 25 | 12.9% | 18.3% | ||
| Q3 25 | 14.7% | — | ||
| Q2 25 | 9.8% | — | ||
| Q1 25 | 8.0% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 20.2% | — | ||
| Q1 24 | 10.9% | — |
每股收益（稀释后）MDXGRMR
| Q4 25 | $0.10 | $0.71 | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $0.06 | — | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.12 | — | ||
| Q1 24 | $0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $49.3M |
| 总债务越低越好 | $18.0M | — |
| 股东权益账面价值 | $256.5M | $232.7M |
| 总资产 | $342.7M | $687.1M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资MDXGRMR
| Q4 25 | $166.1M | $49.3M | ||
| Q3 25 | $142.1M | — | ||
| Q2 25 | $118.9M | — | ||
| Q1 25 | $106.4M | — | ||
| Q4 24 | $104.4M | — | ||
| Q3 24 | $88.8M | — | ||
| Q2 24 | $69.0M | — | ||
| Q1 24 | $48.5M | — |
总债务MDXGRMR
| Q4 25 | $18.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $19.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDXGRMR
| Q4 25 | $256.5M | $232.7M | ||
| Q3 25 | $238.9M | — | ||
| Q2 25 | $216.6M | — | ||
| Q1 25 | $202.8M | — | ||
| Q4 24 | $193.1M | — | ||
| Q3 24 | $181.0M | — | ||
| Q2 24 | $168.0M | — | ||
| Q1 24 | $155.7M | — |
总资产MDXGRMR
| Q4 25 | $342.7M | $687.1M | ||
| Q3 25 | $319.0M | — | ||
| Q2 25 | $291.1M | — | ||
| Q1 25 | $270.4M | — | ||
| Q4 24 | $263.9M | — | ||
| Q3 24 | $243.9M | — | ||
| Q2 24 | $230.2M | — | ||
| Q1 24 | $221.7M | — |
负债/权益比MDXGRMR
| Q4 25 | 0.07× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.64× | 0.88× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDXGRMR
| Q4 25 | $25.0M | $10.7M | ||
| Q3 25 | $29.3M | — | ||
| Q2 25 | $14.4M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $18.8M | — | ||
| Q3 24 | $19.6M | — | ||
| Q2 24 | $21.8M | — | ||
| Q1 24 | $6.0M | — |
现金转化率MDXGRMR
| Q4 25 | 1.64× | 0.88× | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
